What is the treatment for diabetic ketoacidosis (DKA) in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Diabetic Ketoacidosis in Children

The treatment of diabetic ketoacidosis (DKA) in children requires immediate fluid resuscitation with isotonic saline, followed by insulin therapy at 0.1 units/kg/hour, with careful monitoring of electrolytes and gradual correction of acidosis to prevent cerebral edema. 1, 2

Diagnostic Criteria for DKA in Children

  • Blood glucose >250 mg/dL
  • Venous pH <7.3
  • Bicarbonate <15 mEq/L
  • Presence of ketones in blood or urine 1

Initial Management

Fluid Resuscitation

  • Begin with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour for the first 1-2 hours to address dehydration and hypotension 1
  • After initial bolus, calculate fluid deficit and provide rehydration over 48 hours 3
  • Use isotonic solutions initially; subsequent fluid management should be with at least 0.45% saline 3
  • When glucose reaches 250 mg/dL, add 5-10% dextrose to IV fluids while continuing insulin to clear ketones 1

Insulin Therapy

  • Start insulin 1-2 hours after beginning fluid replacement 1, 2
  • Use continuous IV insulin infusion at 0.1 units/kg/hour 1, 3
  • Target glucose decline of 50-75 mg/dL per hour 1
  • If glucose doesn't fall by 50 mg/dL in first hour, double insulin infusion rate hourly until achieving steady decline 1
  • When glucose reaches 250 mg/dL, reduce insulin to 0.05-0.1 units/kg/hour and add dextrose to IV fluids 1

Electrolyte Management

Potassium Replacement

  • Begin potassium replacement when serum levels fall below 5.5 mEq/L and adequate urine output is confirmed 2
  • Use 20-30 mEq potassium (2/3 KCl and 1/3 KPO₄) in each liter of infusion fluid 2
  • If hypokalemia is present at diagnosis, start potassium replacement with fluid therapy and delay insulin until potassium is >3.3 mEq/L 2

Bicarbonate Therapy

  • Not recommended if pH is >7.0 2, 1
  • For pH 6.9-7.0, consider 50 mmol sodium bicarbonate diluted in 200 mL sterile water, infused at 200 mL/h 2
  • For pH <6.9, consider 100 mmol sodium bicarbonate in 400 mL sterile water at 200 mL/h 2

Phosphate Replacement

  • Consider phosphate replacement in patients with cardiac dysfunction, anemia, respiratory depression, or serum phosphate <1.0 mg/dL 2, 1

Monitoring During Treatment

  • Blood glucose: Every 1-2 hours until stable 1
  • Electrolytes, BUN, creatinine: Every 2-4 hours 1
  • Venous pH and anion gap: To evaluate resolution of acidosis 1
  • Neurological status: Frequent checks for signs of cerebral edema 4
  • Serum ketones (preferably β-hydroxybutyrate): Until resolution 1

Complications to Watch For

Cerebral Edema

  • Occurs in 0.5-0.9% of DKA episodes but is the major cause of death in childhood DKA 4
  • Risk factors include severity of acidosis, greater hypocapnia, higher BUN at presentation, and bicarbonate treatment 3
  • Warning signs: Headache, decreased mental status, irritability, abnormal pupillary responses, hypertension, bradycardia
  • Treatment: Immediate administration of mannitol (0.5-1 g/kg) or hypertonic saline 1

Hyperchloremic Acidosis

  • More common with faster fluid administration rates 5
  • Monitor chloride levels during treatment

Resolution and Transition to Subcutaneous Insulin

DKA is considered resolved when:

  • Blood glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3
  • Normalized anion gap
  • Patient is hemodynamically stable 1

After resolution:

  • Transition to subcutaneous insulin
  • Continue IV insulin for 1-2 hours after first subcutaneous dose 1
  • For newly diagnosed type 1 diabetes, initiate multiple-dose insulin therapy 2
  • For type 2 diabetes with resolved DKA, consider metformin while continuing subcutaneous insulin therapy 2

Prevention of Recurrent DKA

  • Provide education on recognition and prevention of DKA
  • Teach sick day management
  • Ensure regular follow-up with healthcare providers 1
  • Address insulin omission, which is the most common cause of recurrent DKA 6

The management of DKA in children requires careful attention to fluid and electrolyte balance, with the primary goal of preventing cerebral edema while correcting metabolic derangements.

References

Guideline

Diabetic Ketoacidosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diabetic ketoacidosis in children and adolescents.

Indian journal of endocrinology and metabolism, 2015

Research

The management of diabetic ketoacidosis in children.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.